Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 10c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 EPS of ($0.62), $0.10 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c